| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054870 | Oral Oncology | 2015 | 8 Pages |
Abstract
MiR-29b acts as an oncomir, promoting cell migration through CX3CL1 suppression, and could be a potential therapeutic target for preventing OSCC progression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Cheng-Ning Yang, Yi-Ting Deng, Jia-Yu Tang, Shih-Jung Cheng, Szu-Ta Chen, Yue-Ju Li, Tai-Sheng Wu, Muh-Hwa Yang, Been-Ren Lin, Mark Yen-Ping Kuo, Jenq-Yuh Ko, Cheng-Chi Chang,